Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
MedTech
JenaValve secures FDA's 1st approval in aortic regurgitation
JenaValve has secured the FDA’s approval for its heart implant, making it the first in the U.S. to treat severe backflow through the aortic valve.
Conor Hale
Mar 18, 2026 10:05am
Novocure gets FDA nod for device targeting pancreatic cancer
Feb 17, 2026 4:15am
Guardant Health gets FDA nod to expand test for colon cancer
Jan 26, 2026 8:15am
After 20 years, Medtronic claims neurostim approval in dystonia
Dec 4, 2025 10:25am
Ceribell nets FDA nod for detecting seizures in preterm newborns
Nov 26, 2025 9:49am
IceCure nabs FDA OK for breast cancer cryoablation treatment
Oct 6, 2025 9:00am
